Clinical Trial Update: Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NS-863 in pulmonary arterial hypertension, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• NS-863

Snippet

Sponsor: NS Pharma, Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: NOT_YET_RECRUITING